Brucke Financial, Inc. Astrazeneca PLC Transaction History
Brucke Financial, Inc.
- $115 Billion
- Q1 2025
A detailed history of Brucke Financial, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Brucke Financial, Inc. holds 8,542 shares of AZN stock, worth $612,803. This represents 0.53% of its overall portfolio holdings.
Number of Shares
8,542
Previous 8,804
2.98%
Holding current value
$612,803
Previous $623 Million
1.56%
% of portfolio
0.53%
Previous 0.54%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,429Shares Held
505MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.1 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.92 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.28 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.24 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $222B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...